Please do not adjust margins
RSC Advances
Page 10 of 14
DOI: 10.1039/C6RA16459E
ARTICLE
Journal Name
(s, 1H), 7.33 (s, 1H), 7.27 (s, 2H), 5.14 (s, 1H), 3.93 (m, 2H), 2.41
(d, J = 17.1, 1H), 2.30-2.20 (m with s at 2.24, 4H), 2.13 (d, J =
16.1, 1H), 1.91 (d, J = 16.0, 1H), 1.07 (t, J = 6.8, 3H), 0.99 (s, 3H),
0.83 (s, 3H); 13C NMR (101 MHz) δ 194.3, 167.0, 150.3, 145.9,
144.7, 133.3, 133.2, 131.2, 128.6, 127.3, 109.7, 103.2, 59.5, 50.6,
35.2, 32.4, 29.5, 26.8, 18.7, 14.5; MS (EI) m/z (%): 411 (M++4, 1),
409 (M++2, 5), 407 (M+, 9), 372 (14), 262 (100), 234 (19); TOF-
HRMS (EI): m/z (M)+ calcd for C21H23Cl2NO3 407.1055; found
407.1062.
melting point: 205-207 oC; FT-IR (KBr): υ(cm-1) = 3280, 3213,
3081, 2941, 1696, 1605, 1514; 1H NMR (300 MHz, EtOH-d6) δ
6.80 (d, J = 1.2 Hz, 1H), 6.72-6.53 (m, 2H), 4.83 (s, 1H), 3.94 (q, J
= 7.1, 2H), 3.66 (s, 3H), 3.63 (s, 3H), 2.35 (d, J = 17.0 Hz, 1H),
2.29-2.19 (m with s at 2.26, 4H), 2.13 (d, J = 16.4 Hz, 1H), 1.98 (d,
J = 16.4 Hz, 1H), 1.09 (t, J = 7.1 Hz, 3H), 0.97 (s, 3H), 0.82 (s, 3H);
13C NMR (101 MHz) δ 194.7, 167.3, 149.7, 148.3, 147.3, 144.9,
140.8, 119.6, 112.0, 111.8, 110.4, 104.2, 59.4, 55.7, 55.6, 50.6,
35.5, 32.5, 29.6, 26.8, 18.6, 14.6; MS (EI) m/z (%): 399 (M+, 33),
370 (10), 262 (100), 234 (21); TOF-HRMS (EI): m/z (M)+ calcd for
C23H29NO5 399.2046; found 399.2056.
Ethyl
4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1d) 36c
melting point: 255-257 oC; FT-IR (KBr): υ(cm-1) = 3277, 3202,
Ethyl
4-(4-fluorophenyl)-2,7,7-trimethyl-5-oxo-
1
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1i) 36c
3078, 2957, 1701, 1649, 1606, 1496; H NMR (400 MHz) δ 8.99
melting point: 193-195 oC; FT-IR (KBr): υ(cm-1) = 3291, 3219,
3078, 2959, 1702, 1607, 1487, 1382, 1212, 853, 531; 1H NMR
(400 MHz) δ 9.06 (s, 1H), 7.14 (m, 2H), 6.99 (m, 2H), 4.83 (s, 1H),
3.96 (m, 2H), 2.40 (d, J = 17.1, 1H), 2.34 – 2.20 (m with s at 2.28,
4H), 2.15 (d, J = 15.8, 1H), 1.96 (d, J = 15.9, 1H), 1.10 (s, 3H), 0.99
(s, 3H), 0.82 (s, 3H); 13C NMR (101 MHz) δ 194.7, 167.2, 160.8 (d,
J = 241.2), 149.9, 145.6, 144.3, 129.6 (d, J = 8.0), 114.8 (d, J =
21.0), 110.4, 103.9, 59.5, 50.6, 35.7, 32.6, 29.5, 26.9, 18.7, 14.6;
MS (EI) m/z (%): 357 (M+, 21), 262 (100), 234 (22); 19F NMR (282
MHz, DMSO) δ -115.39; TOF-HRMS (EI): m/z (M)+ calcd for
C21H24FNO3 357.1740; found 357.1746.
(s, 1H), 7.04 (d, J = 8.2, 2H), 6.73 (d, J = 8.2, 2H), 4.78 (s, 1H),
3.96 (q, J = 6.9, 2H), 3.66 (s, 3H), 2.40 (d, J = 17.0, 1H), 2.35-2.20
(m with s at 2.26, 4H), 2.15 (d, J = 16.0, 1H), 1.96 (d, J = 16.0,
1H), 1.13 (t, J = 6.9, 3H), 1.00 (s, 3H), 0.84 (s, 3H); 13C NMR (101
MHz) δ 194.7, 167.4, 157.7, 149.6, 145.0, 140.5, 128.8, 113.5,
110.6, 104.4, 59.4, 55.3, 50.7, 35.4, 32.5, 29.6, 26.9, 18.7, 14.6;
MS (EI) m/z (%): 369 (M+, 33), 340 (13), 296 (11), 262 (100), 234
(21); TOF-HRMS (EI): m/z (M)+ calcd for C22H27NO4 369.1940;
found 369.1950.
Ethyl
4-(3-bromophenyl)-2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1e)26
melting point: 206-208 oC; FT-IR (KBr): υ(cm-1) = 3273, 3073,
2958, 1702, 1604, 1489, 1380, 1211, 1071, 769; 1H NMR (400
MHz) δ 9.12 (s, 1H), 7.32 – 7.22 (m, 2H), 7.20 – 7.08 (m, 2H),
4.82 (s, 1H), 4.05-3.90 (m, 2H), 2.42 (d, J = 17.2, 1H), 2.38-2.25
(m with s at 2.29, 4H), 2.17 (d, J = 16.2, 1H), 1.99 (d, J = 15.8,
1H), 1.12 (t, J = 6.8, 3H), 1.00 (s, 3H), 0.85 (s, 3H); 13C NMR (101
MHz) δ 194.7, 167.0, 150.7, 150.3, 146.0, 130.8, 130.5, 129.0,
127.0, 121.5, 109.9, 103.4, 59.6, 50.6, 36.5, 32.6, 29.5, 26.8,
18.8, 14.5; MS (EI) m/z (%): 419 (M++ 2, 6), 417 (M+, 6), 262
(100), 234 (23); TOF-HRMS (EI): m/z (M)+ calcd for C21H24BrNO3
417.0940; found 417.0933.
Ethyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-
hexahydroquinoline-3-carboxylate: (1j) 36c
melting point: 242-243 oC; FT-IR (KBr): υ(cm-1) = 3274, 3189,
3076, 2966, 1703, 1649, 1609, 1493, 1349, 1215; 1H NMR (400
MHz) δ 9.22 (s, 1H), 8.09 (d, J = 8.5, 2H), 7.41 (d, J = 8.5, 2H),
4.96 (s, 1H), 3.96 (q, J = 6.9, 2H), 2.43 (d, J = 17.1, 1H), 2.35-2.25
(m with s at 2.31, 4H), 2.18 (d, J = 16.2, 1H), 1.97 (d, J = 16.2,
1H), 1.10 (t, J = 7.0, 3H), 1.00 (s, 3H), 0.81 (s, 3H); 13C NMR (101
MHz) δ 194.7, 166.8, 155.4, 150.5, 146.6, 146.1, 129.2, 123.6,
109.5, 102.8, 59.7, 50.5, 37.1, 32.6, 29.4, 26.9, 18.8, 14.5; MS
(EI) m/z (%): 384 (M+, 15), 262 (100), 234 (22); TOF-HRMS (EI):
m/z (M)+ calcd for C21H24N2O5 384.1685; found 384.1692.
Ethyl
4-(2-chlorophenyl)-2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1f)39
melting point: 207-209 oC; FT-IR (KBr): υ(cm-1) = 3277, 3210,
3073, 2957, 1701, 1649, 1606, 1496, 1380; 1H NMR (400 MHz) δ
9.07 (s, 1H), 7.28 (d, J = 6.8, 1H), 7.24-7.12 (m, 2H), 7.06 (t, J =
7.0, 1H), 5.18 (s, 1H), 3.98-3.87 (m, 2H), 2.41 (d, J = 17.0, 1H),
2.32-2.20 (m with s at 2.24, 4H), 2.13 (d, J = 16.1, 1H), 1.91 (d, J =
16.1, 1H), 1.07 (t, J = 7.1, 3H), 1.00 (s, 3H), 0.84 (s, 3H); 13C NMR
(101 MHz) δ 194.3, 167.2, 150.1, 145.6, 145.4, 132.4, 131.9,
129.4, 127.7, 127.1, 110.0, 103.7, 59.4, 50.7, 35.4, 32.4, 29.6,
26.8, 18.6, 14.5; MS (EI) m/z (%): 375 (M++2, 7), 373 (M+, 22),
338 (39), 262 (100), 234 (48); TOF-HRMS (EI): m/z (M)+ calcd for
C21H24ClNO3 373.1445; found 373.1457.
Ethyl
4-(2-methoxyphenyl)-2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1k)41
melting point: 249-251 oC; FT-IR (KBr): υ(cm-1) = 3284, 3078,
2964, 1689, 1623, 1611, 1488, 1361, 1215, 751; 1H NMR (300
MHz, EtOH-d6) δ 7.15 (d, J = 7.0, 1H), 6.93 (t, J = 7.4, 1H), 6.79-
6.56 (m, 2H), 5.06 (s, 1H), 3.87 (q, J = 7.0, 2H), 3.65 (s, 3H), 2.32
(d, J = 17.0, 1H), 2.26-2.15 (m with s at 2.18, 4H), 2.14-1.97 (m,
1H), 1.91 (d, J = 16.4, 1H), 1.10-0.90 (m, 6H), 0.80 (s, 3H); 13C
NMR (101 MHz) δ 193.8, 167.3, 157.1, 149.9, 144.1, 134.9,
130.5, 126.9, 119.4, 111.0, 108.6, 102.9, 58.7, 55.1, 50.4, 32.8,
32.0, 29.3, 26.2, 18.0, 14.1; MS (EI) m/z (%): 369 (M+, 61), 340
(37), 262 (100), 234 (31); TOF-HRMS (EI): m/z (M)+ calcd for
C22H27NO4 369.1940; found 369.1946.
Ethyl
2,7,7-trimethyl-5-oxo-4-(p-tolyl)-1,4,5,6,7,8-
hexahydroquinoline-3-carboxylate: (1g) 36c
Ethyl
4-(3-ethoxy-4-hydroxyphenyl)-2,7,7-trimethyl-5-
melting point: 263-265 oC; FT-IR (KBr): υ(cm-1) = 3276, 3208,
3078, 2958, 1702, 1648, 1606, 1493, 1282; 1H NMR (400 MHz) δ
8.99 (s, 1H), 7.15-6.90 (m, 4H), 4.79 (s, 1H), 3.95 (m, 2H), 2.39 (d,
J = 17.1, 1H), 2.36-2.10 (m with 2s at 2.25 and 2.18, 8H), 1.95 (d,
J = 16.0, 1H), 1.12 (s, 3H), 0.99 (s, 3H), 0.83 (s, 3H); 13C NMR (101
MHz) δ 194.7, 167.3, 149.8, 145.2 (2c), 135.0, 128.7, 127.8,
110.5, 104.2, 59.4, 50.7, 35.8, 32.6, 29.6, 26.9, 21.0, 18.7, 14.6;
MS (EI) m/z (%): 353 (M+, 18), 262 (100), 234 (18); TOF-HRMS
(EI): m/z (M)+ calcd for C22H27NO3 353.1991; found 353.2005.
oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1l)36c
melting point: 195-196 oC; FT-IR (KBr): υ(cm-1) = 3443, 3282,
3200, 3079, 2959, 1657, 1616, 1493, 1381; 1H NMR (300 MHz,
EtOH-d6) δ 6.74 (s, 1H), 6.52 (s, 2H), 4.79 (s, 1H), 4.02-3.81 (m,
4H), 2.33 (d, J = 17.0, 1H), 2.28-2.18 (m with s at 2.25, 4H), 2.12
(d, J = 16.5, 1H), 1.98 (d, J = 16.4, 1H), 1.27 (t, J = 7.0, 3H), 1.08
(t, J = 7.1, 3H), 0.96 (s, 3H), 0.81 (s, 3H); 13C NMR (101 MHz) δ
194.8, 167.4, 149.6, 146.2, 145.3, 144.8, 139.4, 120.1, 115.4,
113.9, 110.6, 104.5, 64.2, 59.4, 50.7, 35.4, 32.5, 29.6, 26.8, 18.7,
15.2, 14.6; MS (EI) m/z (%): 399 (M+, 30), 370 (11), 262 (100),
Ethyl
4-(3,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydroquinoline-3-carboxylate: (1h) 36c
10 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins